| pubmed-article:19107782 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19107782 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19107782 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
| pubmed-article:19107782 | lifeskim:mentions | umls-concept:C0027415 | lld:lifeskim |
| pubmed-article:19107782 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:19107782 | lifeskim:mentions | umls-concept:C0007328 | lld:lifeskim |
| pubmed-article:19107782 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:19107782 | lifeskim:mentions | umls-concept:C2348519 | lld:lifeskim |
| pubmed-article:19107782 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19107782 | pubmed:dateCreated | 2009-4-13 | lld:pubmed |
| pubmed-article:19107782 | pubmed:abstractText | The role of narcotic use in patients with inflammatory bowel disease (IBD) is poorly defined. We sought to determine the clinical features of patients with IBD who use narcotics and factors associated with the discontinuation of narcotics. | lld:pubmed |
| pubmed-article:19107782 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19107782 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19107782 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19107782 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19107782 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19107782 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19107782 | pubmed:month | May | lld:pubmed |
| pubmed-article:19107782 | pubmed:issn | 1536-4844 | lld:pubmed |
| pubmed-article:19107782 | pubmed:author | pubmed-author:HarmsenW... | lld:pubmed |
| pubmed-article:19107782 | pubmed:author | pubmed-author:LoftusEdward... | lld:pubmed |
| pubmed-article:19107782 | pubmed:author | pubmed-author:SandbornWilli... | lld:pubmed |
| pubmed-article:19107782 | pubmed:author | pubmed-author:ZinsmeisterAl... | lld:pubmed |
| pubmed-article:19107782 | pubmed:author | pubmed-author:DiehlNancy... | lld:pubmed |
| pubmed-article:19107782 | pubmed:author | pubmed-author:HansonKaren... | lld:pubmed |
| pubmed-article:19107782 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19107782 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:19107782 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19107782 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19107782 | pubmed:pagination | 772-7 | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:meshHeading | pubmed-meshheading:19107782... | lld:pubmed |
| pubmed-article:19107782 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19107782 | pubmed:articleTitle | Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: a case-control study. | lld:pubmed |
| pubmed-article:19107782 | pubmed:affiliation | Miles & Shirley Fiterman Center for Digestive Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA. | lld:pubmed |
| pubmed-article:19107782 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19107782 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19107782 | lld:pubmed |
